Table of Contents
What changed
Revenue fell 19.2% to NZ$48.7m from NZ$60.3m in HY21, with the company citing COVID-19 and supply chain disruption. Profit before tax declined 70.8% to NZ$1.3m and NPAT fell 76.6% to NZ$1.0m. Operating cash flow swung to a NZ$1.4m outflow from a NZ$17.5m inflow, and cash on hand dropped to NZ$18.5m from NZ$26.3m. On the balance sheet, trade receivables rose 45.9% to NZ$12.2m while inventories fell 11.2% to NZ$21.0m; total assets and equity both eased modestly. Gross borrowings were not disclosed in the HY22 extract (nil in the prior comparable).
What matters
- Operating leverage worked in reverse. A 19.2% revenue decline translated into a 70.8% PBT decline, pointing to a materially high fixed-cost base in the new all-wool and natural fibres model. Annualised HY22 revenue of NZ$97.4m sits about 13% below the FY21 anchor of NZ$111.6m.
- Cash generation deteriorated sharply. OCF of negative NZ$1.4m against an NPAT of positive NZ$1.0m, combined with capex of NZ$1.6m, produced free cash flow of roughly negative NZ$3.0m versus positive NZ$16.4m a year earlier. This is the single largest read-through from the release.
- The tax line flatters the headline comparison in the wrong direction. The effective tax rate rose to 22.5% from 3.3%, so NPAT fell faster than PBT. PBT growth of negative 70.8% is the cleaner operating read.
Expectations
No quantified guidance, forward-work pipeline or stated targets were disclosed. Management describes the result as "in line with management expectations" but does not publish that expectation. Historical shape offers limited help: HY21 represented 54% of FY21 revenue but 247% of FY21 NPAT, because FY21 swung to a second-half loss of about NZ$2.5m on an implied second-half NPAT basis. That prior-year shape is an unreliable template for FY22 under the new strategy. The release supports a view that the HY22 run-rate is below FY21; it does not support any judgement on recovery path or margin recovery into H2.
Quality of result
Earnings quality looks weak rather than durable. The NZ$1.0m NPAT is not supported by cash: operating cash flow deteriorated by NZ$18.9m year-on-year, a swing several multiples the size of the earnings decline. Receivable days lengthened to 45.7 from 25.3 (a 20-day extension), and inventory days rose to 78.6 from 71.5, so the P&L is partly being funded by working capital build rather than by customer collections. No non-recurring items were identified to bridge the gap, and the company did not provide an EBITDA reconciliation comparable to FY21's normalised measure, reducing visibility on underlying trading performance. ROE fell to 5.3% from 23.1%.
Unresolved
- What portion of the revenue decline is COVID/supply-chain timing versus structural, given the strategy shift to all-wool and natural fibres?
- Why did receivables rise 45.9% while revenue fell 19.2%, and is any of that balance at risk?
- What is the current debt facility position and covenant headroom, given gross borrowings are not visible in the supplied HY22 extract and cash has fallen NZ$7.8m year-on-year?
- Is there a normalised or reconciled EBITDA for HY22 on the same basis as FY21, and what is the expected H2 shape under the new strategy?
This briefing cannot assess volume versus price mix, margin bridge, channel or geographic concentration, or FY22 guidance, because none of those disclosures are present in the supplied data.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $48.7m | $60.3m | -19.2% ↓ |
| Net profit after tax | $1.0m | $4.3m | -76.6% ↓ |
| Net cash inflow from operating activities | −$1.4m | $17.5m | -107.9% ↓ |
| Operating profit | $1.7m | $5.0m | -65.0% ↓ |
| Profit before tax | $1.3m | $4.4m | -70.8% ↓ |
| Cash and cash equivalents | $18.5m | $26.3m | -29.5% ↓ |
| Total assets | $75.9m | $80.4m | -5.6% ↓ |
Reference: annolyse.ai/briefings/brw-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | -70.8% | — | cleaner earnings measure |
| Effective tax rate | 22.5% | 3.3% | — |
| FCF pre-lease | −$3.0m | $16.4m | −$19.4m |
| FCF post-lease | −$3.0m | $16.4m | −$19.4m |
| FCF / NPAT | -296.3% | 384.8% | complementary conversion metric |
| Capex % revenue | 3.3% | 1.8% | — |
| Capex | −$1.6m | −$1.1m | −$0.5m |
| Debtor days | 45.7 | 25.3 | +20.4 days |
| Inventory days | 78.6 | 71.5 | +7.1 days |
| Operating working capital | $33.3m | $32.1m | +$1.2m absorbed |
| Trade debtors | $12.2m | $8.4m | +$3.8m |
| Gross borrowings | — | $0.0m | — |
| Payout ratio vs NPAT | 0.0% | — | — |
| Payout ratio vs FCF pre-lease | 0.0% | — | covered |
| ROE (annualised) | 5.3% | 23.1% | Weakening |
| HY21 share of FY21 revenue | 54.0% | — | Other half was 46.0% |
| HY21 share of FY21 NPAT | 247.1% | — | Other half was -147.1% |
| Profit from continuing operations | $1.0m | $4.3m | −$3.3m |
Reference: annolyse.ai/briefings/brw-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.